Fast-Tracking combination prevention


The expanded availability of antiretroviral medicines and their beneficial effect in suppressing the viral loads of people living with HIV is contributing to a reduction in new HIV infections. However, on its own this is not enough. To end the AIDS epidemic by 2030, the scale-up of targeted combination prevention efforts is urgently required. 

In this new publication, UNAIDS highlights the importance of focused and integrated combination HIV prevention programmes. The report re-defines what combination prevention means and looks at the elements that make combination prevention successful and how effective they can be.

UNAIDS specifies six requirements that countries should follow to maximize the impact of combination prevention programmes. These are: a strong commitment to HIV prevention, including sufficient budget allocation; focusing prevention programmes on where they are needed; strengthening synergies between different combination prevention and treatment programme elements; delivery at scale; incorporating and monitoring scale-up; and establishing clear targets and accountability mechanisms for all involved.

October 29, 2015
Year of publication
Resource types
Reports and Fact sheets
UNAIDS, antiretroviral drugs, antiretroviral therapy, ARVs, ART, treatment, HIV, viral load, combination HIV prevention, prevention programmes, HIV prevention

Similar Resources

Timely access to antiretroviral treatment (ART) is vital to ensuring safe motherhood and reducing vertical transmission. Treatment guidance and programming has changed dramatically in recent years.

In all countries where there is an HIV epidemic, certain subgroups of the population are at greater risk of HIV than others. These “key” populations include female sex workers (FSWs), men who have sex with men (MSM), transgender people, and people who inject drugs.

In late 2015, the Linkages Across the Continuum of HIV Services for Key Populations (LINKAGES) project established a global acceleration initiative to fast-track and strengthen delivery of a comprehensive package of health services for key populations (KPs) at scale. In this context, “…

Remarkable progress is being made on HIV treatment. Ahead of World AIDS Day, UNAIDS has launched a new report showing that access to treatment has risen significantly. In 2000, just 685 000 people living with HIV had access to antiretroviral therapy.

For people who may have been exposed to HIV, knowledge is critical to making informed decisions about their future. An HIV test is a serious event with potentially serious outcomes. But no matter the result, the test provides vital information.


The goal of virtual elimination of horizontal and mother-to-child HIV transmission in South Africa (SA) has been proposed, but there have been few systematic investigations of which interventions are likely to be most critical to reducing HIV incidence.

Advances in biomedical technologies provide potential for adolescent HIV prevention and HIV-positive survival.

To understand the uptake of HIV services by adolescent women, the authors conducted a retrospective analysis of patient-level data (2011–2013) on services for antenatal care (ANC) and prevention of mother-to-child transmission (PMTCT) in 36 facilities in 5 districts in Zimbabwe.

In 2006, WHO set forth its vision for a public health approach to delivering antiretroviral therapy. This approach has been broadly adopted in resource-poor settings and has provided the foundation for scaling up treatment to over 19·5 million people.

The Pediatric-Adolescent Treatment Africa (PATA) and the Positive Action for Children Fund (PACF) have worked across 9 countries and facilitated 36 clinic-community collaborations through their partnership on the three-year Clinic-CBO Collaboration (C3) Programme, which aims to…